- $427.37m
- $150.25m
- $4.66m
RCS - PureTech Health PLC - PRTC's Deupirfenidone Granted FDA & EU ODD for IPF
AnnouncementRCS - PureTech Health PLC - PureTech to Present at the JP Morgan Conference
AnnouncementREG - PureTech Health PLC - PureTech Appoints Robert Lyne as CEO
AnnouncementREG - PureTech Health PLC - Results of AGM on June 16, 2025 – Update Statement
AnnouncementREG - PureTech Health PLC - Holding(s) in Company
AnnouncementRCS - PureTech Health PLC - PRTC: Successful FDA Meeting; IPF Phase 3 in 1H26
AnnouncementRCS - PureTech Health PLC - PRTC's Gallop: Positive Initial Topline AML Data
AnnouncementREG - PureTech Health PLC Citigroup Inc - Holding(s) in Company
AnnouncementREG - PureTech Health PLC Citigroup Inc - Holding(s) in Company
AnnouncementRCS - PureTech Health PLC - PRTC: New LYT-200 AML Data + Update at ASH
AnnouncementRCS - PureTech Health PLC - PRTC: New IPF Data Show Benefit in Older Patients
AnnouncementREG - PureTech Health PLC - Holding(s) in Company
AnnouncementREG - PureTech Health PLC Citigroup Inc - Holding(s) in Company
AnnouncementREG - PureTech Health PLC Citigroup Inc - Holding(s) in Company
AnnouncementREG - PureTech Health PLC Citigroup Inc - Holding(s) in Company
AnnouncementREG - PureTech Health PLC - Holding(s) in Company
AnnouncementRCS - PureTech Health PLC - PRTC: New IPF Data Show Switch Patients Stabilized
AnnouncementREG - PureTech Health PLC - PDMR DEALING - PURCHASE OF SHARES
AnnouncementREG - PureTech Health PLC - Holding(s) in Company
Announcement